BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Obermann W, Friedrich A, Madhugiri R, Klemm P, Mengel JP, Hain T, Pleschka S, Wendel H, Hartmann RK, Schiffmann S, Ziebuhr J, Müller C, Grünweller A. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity. Viruses 2022;14:519. [DOI: 10.3390/v14030519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Schiffmann S, Henke M, Seifert M, Ulshöfer T, Roser LA, Magari F, Wendel H, Grünweller A, Parnham MJ. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System. IJMS 2023;24:5872. [DOI: 10.3390/ijms24065872] [Reference Citation Analysis]
2 Wong KH, Lim C, Yip AJW, Farouk IA, Zabidi NZ, Low ZY, Lal SK. Repurposing Drugs for Viruses and Cancer: A Novel Drug Repositioning Strategy for COVID-19. Drug Repurposing for Emerging Infectious Diseases and Cancer 2023. [DOI: 10.1007/978-981-19-5399-6_18] [Reference Citation Analysis]
3 Schiffmann S, Gunne S, Ulshöfer T, Henke M, Roser LA, Schneider A, Cinatl J, Thomas D, Schreiber Y, Wagner PV, Grünweller A, Parnham MJ. In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol. Pharmaceuticals 2022;15:1086. [DOI: 10.3390/ph15091086] [Reference Citation Analysis]